der die und bei von mit eine ist werden den einer für sind des das oder auch nicht als auf ein durch nach zur sich wird kann dem nur aus können vor über dass therapie patienten wie einem keine sie bis wurde diese aber schwangerschaft wurden unter einen sowie zum eines sollte beim hat jedoch noch wenn muss bzw man sein gegen dieser infektionen während haben behandlung infektion zwischen anwendung klk sehr anderen meist mehr ohne aufgrund risiko gibt erreger kinder eingesetzt tab häufig studien andere insbesondere trimenon bisher möglich jahren abb kindern müssen kommt menschen besteht dies sollten war 
los con del las una por para pacientes como della che más dei virus son delle infección tratamiento enfermedad sono puede casos ser entre nel sin han este riesgo pueden alla durante infecciones diagnóstico esta più gli mayor sobre tra paciente caso también degli estos forma debe salute años stato influenza síntomas otros niños aunque neumonía mediante nei hasta nella parte días estudios está pero stati rischio uso enfermedades studio importante hanno estudio muy anche frecuencia essere tanto presencia embargo stata clínica cuando dos frecuente salud tipo tienen pulmonar menos aguda epoc datos uno solo otras sistema causa fiebre pazienti 
sars-cov sars preprint covid cases mers-cov patients license infection coronavirus copyright medrxiv holder china respiratory author/funder peer-reviewed reported https://doi.org outbreak doi transmission disease days virus mers international confirmed case infected display severe granted perpetuity made data symptoms wuhan epidemic health figure countries spread study contact camels biorxiv onset number patient march cov including ncov day early ace viral cc-by-nc-nd hospital syndrome saudi coronaviruses control january rate table february allowed clinical reserved rights permission infections reuse province pneumonia time deaths arabia human illness identified fever measures acute high middle people chinese positive showed world asymptomatic east mild camel public found period 
data information methods analysis number based set method model network approach results system models time research studies systems e.g prediction database process study search algorithm figure table structure approaches features fig performance networks order tools design identify provide score proposed accuracy i.e case knowledge terms large values important function sequence section classification test applied dataset types selected step experimental tool articles work literature problem specific techniques multiple developed authors single relevant distance quality defined related sets biological parameters considered potential small shown algorithms size learning computational obtained predict field software target space nodes input application selection paper high point similar 
respiratory influenza children study infection viral patients virus infections viruses rsv asthma age studies symptoms years clinical pneumonia disease cases acute tract severe illness infants group detected common data lower nasal found adults bacterial reported hmpv days hrv table months positive compared significant risk subjects rhinovirus samples airway severity pathogens year pneumoniae cough human higher groups hbov identified exacerbations hospital upper increased bronchiolitis prevalence detection adenovirus including rate wheezing hospitalized similar included seasonal analysis results rates specimens significantly period number young incidence copd observed high population association fever parainfluenza chronic piv shown aged findings performed allergic factors cold test season 
protein binding residues structure domain proteins peptide fig amino site peptides activity structural pro structures sequence acid figure interactions domains residue protease complex interaction region sars-cov enzyme substrate acids shown sites cleavage affinity form active molecular crystal fusion similar hydrophobic conserved catalytic conformation c-terminal loop model found n-terminal chain surface table observed position bound human proteases bind conformational receptor molecules data group motif regions fold identified helix cysteine inhibitors side ligand bond molecule hydrogen predicted specificity docking pdb rbd analysis determined chains studies mutant function sequences core enzymes pocket results inhibitor formation forms mutations substrates functional state cys based energy 
cells fig cell protein virus figure min control infection infected incubated expression data performed assay pbs results medium analysis antibody previously observed shown buffer culture determined added serum showed compared study washed experiments treated detected samples analyzed plates usa levels antibodies obtained total collected viral measured activity purified times concentration significantly western vero days incubation effect significant group time transfected staining diluted temperature test treatment expressed supernatant determine presence vector mouse strain day plasmid human rna kit stained previous cultures level fold dilution pcr room hours recombinant elisa prepared blot standard supernatants titers mg/ml invitrogen fixed harvested concentrations positive supplemented 
cells cell lung expression levels increased immune mice inflammatory ace human activation response role inflammation effects receptor studies cytokines activity production macrophages epithelial tissue function receptors cytokine shown disease factor increase effect responses including blood system tumor cancer injury induced found development important treatment significantly patients protein reduced mechanisms signaling model diseases endothelial lps liver type ang neutrophils demonstrated addition release growth study damage vivo models compared factors plasma decreased airway tissues tlr pulmonary involved innate expressed vitro pathway normal lungs mechanism group potential proliferation alveolar apoptosis pathways secretion activated molecules high therapeutic gene induce mouse showed stress significant vascular 
model number data time population rate epidemic cases models individuals transmission disease case period infected distribution results values figure fig infectious probability parameters estimated effect average study estimates infection rates analysis outbreak table size individual total contact control estimate dynamics observed i.e based variables effects parameter network spread higher growth susceptible days incidence increase system due function risk impact level measures state change large shown day spatial social peak relative factors expected assumed initial contacts high shows scenario calculated age interval set significant proportion reproduction influenza information point patterns ratio similar regression variable simulation show density small process equation numbers 
rna nsp viral protein sequence virus replication genome mrna proteins translation viruses dna orf synthesis gene fig rnas sequences site region structure transcription end polymerase mutant mrnas shown figure mutations genomic mhv codon nucleotides vitro activity sites expression strand nucleotide mutants frameshifting complex initiation rdrp structural cleavage template cells products genomes conserved structures cellular utr similar cdna host genes trna presence mutation regions required downstream recombination found base plasmid ribosomal amino coronavirus frame mechanism function elements ribosome product specific replicase efficiency transcripts domain role helicase frameshift studies subgenomic present addition small cap form coding stem secondary system deletion recombinant pseudoknot 
hiv activity antiviral viral virus drug treatment compounds drugs hcv inhibitors inhibition replication cells sirna cell effects compound effect target infection effective vitro therapeutic clinical studies viruses hbv human inhibit inhibitor therapy hsv potential active inhibitory development resistance efficacy vivo influenza ribavirin showed potent reported agents rna shown targeting combination treated infections concentrations delivery study assay targets sirnas action inhibited toxicity trials dose hepatitis including reduction group tested dna screening reduced activities concentration derivatives administration addition mechanism demonstrated entry cellular found high protease liver results acid table model rnai assays mice cancer cytotoxicity interferon significant infected molecules developed approved compared 
air water temperature particles exposure environmental room concentration airborne environment flow ventilation time high study aerosol contamination studies surface surfaces fig conditions system building area pressure wind transmission particle risk rate size source contaminated concentrations shown found filter indoor higher control low inactivation due waste process equipment cleaning sampling respiratory disinfection systems test droplets humidity treatment viruses efficiency table results contact heat food buildings lower level areas pollution mask pathogens removal aerosols transport volume effects reduce rooms bacteria human large materials e.g levels effect quality total chemical material droplet measured temperatures gas energy safety infectious standard reduction velocity hand body 
genes gene expression proteins analysis protein human identified genetic cell study data expressed studies table mir figure cancer dna response found levels functional host genome number pathways allele cells including identify disease involved microarray significant pathway mirnas samples biological alleles specific sequencing mirna interactions molecular performed level variants snps transcripts target function small genomic multiple differentially factors development transcription mutations mouse compared based identification association mrna analyses total single control regulation immune complex significantly cellular differences highly high variation approach potential exon chromosome rna tissues selection snp lines role selected class transcriptional targets results processes fold observed controls phenotype lncrnas 
disease treatment blood signs dogs clinical cats diarrhea normal fluid horses common include therapy cases diagnosis small increased body intestinal mg/kg weight occur animals hours administration pain abdominal result days heart weeks severe examination loss affected pregnancy ferrets chronic age muscle serum present foals acute time diet concentrations large liver pressure milk rate occurs oral gastric effects increase cardiac gastrointestinal food water rabbits important administered animal recommended hepatic neonatal obstruction infants commonly decreased results drugs birth concentration surgical high urine function failure left dose reported performed plasma condition including feeding vitamin effective skin volume abnormalities test caused months patient protein 
pedv ibv van tgev birds chickens een chicken het poultry avian strain pdcov ndv strains met bij eggs china piglets egg zijn dpi group voor chicks flocks igy bird aiv inoculated ducks turkey door virulent die worden ped trachea virus dat ook day-old allantoic bronchitis spf mortality kan wordt tcov embryos als signs tracheal porcine tot embryonated live field commercial duck attenuated pathogenicity aan niet deze turkeys eid groups hpai intestinal kidney respiratory vaccine broiler ipec-j papn industry beaudette ibvs mass apmv embryo farms kunnen dit cavanagh hens economic spike dan diarrhea ibdv flock losses epidemic prcv acute fluid production 
surface solution reaction acid concentration nanoparticles dna high method fig chemical properties water obtained molecules due size temperature system mass cell applications fluorescence mixture process conditions based activity synthesis figure compounds binding protein biological reported detection addition range low group particles shown yield analysis formation systems sample presence molecular nps added min potential spectra chromatography developed time membrane higher ion prepared groups proteins methods delivery ions applied target mmol materials product lipid phase column structure increase observed found concentrations small effect results light nmr complex stability showed signal metal aptamers table ratio magnetic form gold compound acids technique application compared 
virus cells proteins membrane protein cell viral viruses fusion entry surface particles host receptor infection membranes cellular binding virions lipid envelope shown replication golgi formation receptors glycoproteins hiv plasma vesicles transport glycoprotein studies found role domain assembly acid required influenza complex virion interaction specific capsid process form intracellular release fig cytoplasmic structures attachment similar human involved infected pathway cleavage budding presence transmembrane function important interactions particle addition cholesterol cytoplasm glycosylation target sialic enveloped microscopy localization type present structural mechanism endocytosis acids sites bind amino site signal observed infectivity env secretory domains small molecules early ebov electron trafficking low components processing 
patients treatment clinical patient study blood therapy disease risk results group infection days pneumonia diagnosis acute mortality severe cases years lung pulmonary hospital infections studies significant high performed compared time higher failure increased day age data rate chest respiratory icu treated showed levels reported positive symptoms months analysis chronic serum recipients admission transplant test median incidence received due methods lower early included care including case factors syndrome common fever transplantation groups significantly findings outcome cmv ventilation antibiotic found criteria complications children outcomes considered plasma level cap dose normal count negative diagnostic conclusion low table antibiotics management sepsis evidence period history 
sequences viruses sequence strains virus genome species gene viral analysis phylogenetic amino bat strain nucleotide sequencing bats genes acid isolates genomes human table fig genetic identified study found host region samples orf protein rna reads recombination detected evolution related diversity identity tree regions based mutations evolutionary group figure selection showed genbank genomic data dna similar genotype codon observed high sites family isolated previously complete sequenced including conserved mutation variants number coronaviruses analyses genotypes genus performed shown alignment positive similarity reported obtained coronavirus proteins type reference studies present accession closely length lineage compared trees isolate hev hosts china pcr differences molecular 
vaccine antibodies vaccines antibody immune virus responses mice protein antigen response igg vaccination cells recombinant neutralizing antigens protection dna human immunization cell immunity epitopes challenge proteins specific development studies viral serum production immunized mabs epitope protective high gene sera vector vectors titers influenza neutralization clinical vaccinated expression effective efficacy animals developed mucosal shown induced animal system dose induce iga infection group antigenic delivery adjuvant viruses mab immunogenicity produced hiv study surface potential inactivated monoclonal vlps based peptides attenuated humoral strain peptide administration elisa groups levels strains demonstrated live target expressing binding expressed highly cellular safety single including humans weeks mouse 
health public countries global research international development national people social china world government economic disease diseases risk information response system policy management systems services states local human security tourism including years important resources state country community market control issues support industry major level access chinese work capacity areas impact time change provide medical million food crisis approach process regional political population media developing scientific disaster united efforts science activities future risks developed potential made key travel role events part urban life products surveillance costs safety year organization organizations technology trade society service financial make challenges include pandemic funding agencies case 
cells mice infection cell cns brain immune virus viral disease response infected expression mouse responses day neurons studies role macrophages levels mhv lymphocytes days increased observed antigen activation animals model astrocytes microglia results shown demyelination found inflammatory tissue production specific compared t-cell mhc peripheral cytokines class myelin system memory vivo data induced spinal ccr cytokine control acute cxcl human similar spleen blood activated dcs ccl autoimmune neuronal number antigens cord early antibodies chronic infections type vitro rats eae receptor patients effector antibody high present models mechanisms ifn numbers function study detected fig stimulation development expressed showed induction suggest murine time 
bacteria bacterial resistance coli strains species plant antimicrobial plants isolates activity work acid isolated aureus found microbial growth antibiotic extract antibiotics pathogens production food mrsa organisms resistant showed study reported toxin present salmonella results spp extracts form microorganisms microbiota compounds strain effects information aeruginosa treatment effect products colonization activities fungi mic including fish oral fungal staphylococcus group gut potential antibacterial intestinal culture susceptibility gram-negative time leaves methods toxins virulence submitted section cancer water due agar important pathogenic medicine vitro genes pneumoniae active total studies sources pathogen microbes biofilm major agents microbiome system type based natural cultures gram-positive report high properties 
health care study patients medical hospital risk patient control participants staff hospitals data healthcare information emergency public infection training studies outbreak workers pandemic reported disease surveillance measures time clinical intervention group system research response including included management support work number nurses survey prevention practice table knowledge community treatment influenza level provide contact infectious factors education significant sars review students general conducted guidelines people high hand department social isolation respondents results physicians symptoms important groups facilities individual years based hcws procedures national provided personal diseases members hygiene personnel home interventions team family cases found quality identified services analysis critical resources practices 
cells lesions disease infection tissue fig cell present lung cases common tissues occur small epithelium animals include necrosis epithelial clinical liver diagnosis occurs pulmonary normal chronic skin nasal acute inflammation mucosa lymph infections severe pneumonia large affected signs tract lungs respiratory inflammatory found reported species rats caused result similar areas form examination lesion alveolar type commonly surface nodes macrophages develop characterized primary tumors edema including lymphocytes virus bacterial interstitial loss presence secondary syndrome dogs mucosal infected observed organs due rare systemic diffuse damage glands mild features blood intestine occasionally rabbits system organisms ocular frequently focal vessels neutrophils findings involvement sections 
samples detection pcr assay dna positive sample assays rna virus viral results sensitivity clinical rt-pcr test amplification detected methods specimens diagnostic reaction primers testing viruses negative method detect tests real-time primer nucleic laboratory specific specificity performed tested diagnosis culture molecular target probes probe min table rapid pathogens kit analysis acid gene control sensitive standard time system high laboratories developed study extraction based identification obtained blood sequencing number multiplex products reverse sequence collected hybridization human single sequences low serum reference specimen conventional designed polymerase amplified techniques pathogen antigen extracted diagnostics presence result elisa applied copies screening including lamp step detecting compared 
virus disease infection human transmission viruses infections diseases infectious species humans host infected cases animal pathogens animals outbreaks fever spread influenza risk viral pathogen outbreak population including populations potential important reported dengue countries agents health high areas hosts contact zoonotic caused years wild emerging africa transmitted studies control recent world exposure surveillance include individuals malaria rabies occur avian severe agent common e.g hepatitis vaccine united states endemic emergence case laboratory illness factors found due mortality evidence highly natural ebola people major food wildlife reservoir symptoms hiv large epidemic measles early clinical genetic research asia blood environmental respiratory identified pathogenic syndrome 
cells viral infection protein ifn proteins virus activation expression signaling replication cell response host type tlr antiviral pathway autophagy viruses immune ifitm cellular rna activity apoptosis role innate irf induction production phosphorylation transcription infected pathways isg shown dna degradation induced stat rig-i nuclear levels genes atg complex responses kinase including factor eif human stress figure gene inhibition studies important binding induce function mechanisms factors interaction mrna involved ifns iav mechanism domain caspase family inhibit interferon activated dsrna target death addition results trim required nf-κb cycle mediated mda found pkr functions hcv mitochondrial regulation specific induces infections ubiquitin ifit dependent increased 
calves cats pigs animals study infection dogs group samples days disease diarrhea virus cattle infected clinical age animal groups serum milk rotavirus bovine positive feline piglets reported found table observed calf signs fecal day detected control studies prrsv fip swine pig cat high farms higher herds porcine significant pcv canine results intestinal antibodies weeks collected compared cows prevalence herd period infections colostrum farm diarrhoea time test present coronavirus shedding blood respiratory feces antibody cpv veterinary strain dairy fcov enteric feed negative number fipv experimental differences type significantly presence strains low mortality showed bvdv considered increased production healthy fiv elisa similar 
les des une est dans par sont pour chez sur avec cas d'une qui pas être ces peut d'un ont été traitement cette aux mais patients virus après diagnostic elle maladie comme ans deux entre souvent très risque peuvent leur moins fait sans l'enfant mois cours doit n'est soit clinique jours syndrome cellules aussi même ainsi dont infections son enfants plusieurs bien recherche était type présence permet signes avant lors sous niveau elles vers respiratoire lésions trois prise anticorps peu également forme nombre donc alors selon pendant chronique d'autres patient charge respiratoires certains ils tout notamment aiguë voie parfois formes 
